Overview

Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

Status:
Unknown status
Trial end date:
2020-07-01
Target enrollment:
0
Participant gender:
All
Summary
A randomized comparison of topical nitroglycerin versus placebo gel for prevention of radial artery occlusion after transradial catheterization.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Total Cardiovascular Solutions
Treatments:
Nitroglycerin
Criteria
Inclusion Criteria: Patients referred for cardiac catheterization.

-

Exclusion Criteria:

- 1: Absence of informed consent. 2: Known allergy to nitroglycerin. 3: Ad-hoc PCI 4:
Previous ipsilateral TRA. 5: Warfarin or NOAC therapy. 6: Systolic blood pressure <
100 mmHg. 7: Critical aortic stenosis (AVA < 0.6 sq.cm) 8: Inability to administer
unfractionated heparin. 9: Need for post-procedural use of heparin (UFH, LMWH) 10:
Raynaud's disease. 11: Sheathless technique or use of > 11 cm sheath. 12: History of
intractable headache of any cause OR Migraine headache.